New Strong Buy Stocks for January 6th

Zacks01-06

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Alaska Air Group, Inc. ALK: This airline company has seen the Zacks Consensus Estimate for its current year earnings increasing 19% over the last 60 days.

Alaska Air Group, Inc. Price and Consensus

Alaska Air Group, Inc. price-consensus-chart | Alaska Air Group, Inc. Quote

Ashford Hospitality Trust, Inc. AHT: This real estate investment trust firm has seen the Zacks Consensus Estimate for its current year earnings increasing 86.5% over the last 60 days.

Ashford Hospitality Trust Inc Price and Consensus

Ashford Hospitality Trust Inc price-consensus-chart | Ashford Hospitality Trust Inc Quote

NRx Pharmaceuticals, Inc. NRXP: This bio-pharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.

NRx Pharmaceuticals, Inc. Price and Consensus

NRx Pharmaceuticals, Inc. price-consensus-chart | NRx Pharmaceuticals, Inc. Quote

Pro-Dex, Inc. PDEX: This medical device contract manufacturer company has seen the Zacks Consensus Estimate for its current year earnings increasing 40.9% over the last 60 days.

Pro-Dex, Inc. Price and Consensus

Pro-Dex, Inc. price-consensus-chart | Pro-Dex, Inc. Quote

eGain Corporation EGAN: This customer service infrastructure software company has seen the Zacks Consensus Estimate for its current year earnings increasing 77.8% over the last 60 days.

eGain Corporation Price and Consensus

eGain Corporation price-consensus-chart | eGain Corporation Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Ashford Hospitality Trust Inc (AHT) : Free Stock Analysis Report

Alaska Air Group, Inc. (ALK) : Free Stock Analysis Report

eGain Corporation (EGAN) : Free Stock Analysis Report

Pro-Dex, Inc. (PDEX) : Free Stock Analysis Report

NRx Pharmaceuticals, Inc. (NRXP) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.